Home › Products › Oncology › Intuca 150mg Tablet
Intuca 150mg Tablet
Salt Composition: TUCATINIB
- Manufacturer: INTAS PHARMACEUTICALS LTD
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Store below 30°C in a dry place, away from direct sunlight. Keep in the original blister or bottle until ready to use. Do not freeze or expose to moisture. Keep out of reach of children and pets. Safely discard expired or unused capsulesâdo not flush them.
₹6150.00₹7500.00
Inclusive of all taxes
Product Introduction
Intuca 150mg Tablet is a medicine used to treat HER2-positive breast cancer, particularly when the disease has spread to other parts of the body, including the brain. It is typically administered alongside two other medicines—trastuzumab and capecitabine.
This medicine works by blocking HER2, a protein that promotes cancer cell growth. By inhibiting this protein, tucatinib helps slow or stop cancer progression. Intuca 150mg is a targeted therapy rather than chemotherapy, meaning it specifically targets cancer cells whilst causing less damage to healthy cells.
The medicine is prescribed only under medical supervision, and regular monitoring during treatment is necessary to ensure the drug is working safely and effectively.
Common side effects of Intuca 150mg include diarrhoea, fatigue, nausea, and changes in liver enzyme levels. Inform your doctor if you experience any side effects or unusual symptoms during treatment.
Uses
Intuca 150mg Tablet is used for: HER2-positive advanced or metastatic breast cancer Brain metastases in HER2+ breast cancer patients Use in combination with trastuzumab and capecitabine after previous HER2-directed therapies This therapy is typically considered when other standard HER2 treatments have become ineffective.
How it works
Intuca 150mg Tablet belongs to a group of medicines known as tyrosine kinase inhibitors (TKIs). It works by: Specifically targeting the HER2 receptor, a protein that promotes cancer cell growth Blocking HER2-related signaling pathways that drive tumor progression Working synergistically with other anticancer drugs like trastuzumab and capecitabine Crossing the blood-brain barrier to treat cancer that has spread to the brain This focused mechanism helps slow disease progression while minimizing impact on normal cells.
Side Effects
Common Side Effects Some people may have: Loose motion (diarrhea) Feeling very tired Nausea or vomiting Mouth sores Less hunger Red or sore hands and feet Liver test changes (seen in blood reports) These usually go away with time or treatment. Tell your doctor if any feel too strong or last long. Serious Side Effects (Call Your Doctor Right Away) Yellow skin or eyes (could mean a liver problem) Bad diarrhea with weakness Trouble breathing or swelling (could be an allergy) High fever or infections Report any unexpected or persistent side effects to your doctor immediately.
References
- https://www.ncbi.nlm.nih.gov/books/NBK595112/
- https://www.nejm.org/doi/full/10.1056/NEJMoa1914609
- https://pubchem.ncbi.nlm.nih.gov/compound/Tucatinib
Safety Advice
Pregnancy: Unsafe Use of this medicine is not recommended during pregnancy. Women of childbearing potential should use effective contraception during treatment and for at least 1 week after the last dose to avoid potential harm to the unborn baby.
Lungs: Consult Your Doctor Intuca 150mg Tablet should be used with caution in lung cancer patients, and only under the supervision of an oncologist, as it may cause serious side effects like liver toxicity and diarrhea.
Breastfeeding: Consult Your Doctor Breastfeeding is not advised while taking this medicine, as it may pass into breast milk and could harm the baby. Talk to your doctor about safer alternatives or when it's safe to resume breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.